IL-6 as a Mediator of the Association Between Traditional Risk Factors and Future Myocardial Infarction A Nested Case-Control Study

被引:10
|
作者
Zegeye, Mulugeta M. [1 ]
Andersson, Jonas S. O. [2 ]
Wennberg, Patrik [3 ]
Repsilber, Dirk [1 ]
Sirsjo, Allan [1 ]
Ljungberg, Liza U. [1 ]
机构
[1] Orebro Univ, Cardiovasc Res Ctr, Sch Med Sci, Sodra Grev Rosengatan 32, S-70362 Orebro, Sweden
[2] Umea Univ, Dept Publ Hlth & Clin Med, Skelleftea Res Unit, Umea, Sweden
[3] Umea Univ, Dept Publ Hlth & Clin Med, Family Med, Umea, Sweden
基金
瑞典研究理事会;
关键词
atherosclerosis; acute coronary syndrome; biomarker; hypertension; smoking; CORONARY-HEART-DISEASE; INTERLEUKIN-6; RECEPTOR; MENDELIAN RANDOMIZATION; TARGETING INTERLEUKIN-6; CARDIOVASCULAR-DISEASE; INFLAMMATORY MARKERS; CIRCULATING LEVELS; SOLUBLE GP130; TNF-ALPHA; ATHEROSCLEROSIS;
D O I
10.1161/ATVBAHA.120.315793
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Studies elucidating the importance of IL (interleukin)-6 trans-signaling associated with risk of future myocardial infarction (MI) are scarce. Additionally, whether elevation in IL-6 explains part of the association between traditional risk factors and future MI has not been explored. Approach and Results: We conducted a nested case-control study including a total of 584 participants (292 cases and 292 controls) from Vasterbotten Intervention Programme and MONICA (Multinational Monitoring of Trends and Determinants in Cardiovascular Disease) cohorts. At baseline, plasma cholesterol levels were measured, and clinical characteristics of participants were collected. In this study, we measured the plasma concentration of IL-6, sIL-6R (soluble IL-6 receptor), and sgp130 (soluble-glycoprotein130). To estimate extent of IL-6 trans-signaling, we estimated plasma concentration of a novel biomarker, the IL-6 binary complex. IL-6 binary complex concentration was significantly elevated in participants who experienced MI compared with those who did not. Univariate analyses showed that a 10-fold increase in IL-6 binary complex was associated with 3.6x higher risk of future MI (95% CI relative risk, 2.0-6.5, P<0.001). Receiver operating characteristics analyses revealed that the predictive performance of IL-6 binary complex (area under the curve, 0.614) was equivalent to that of IL-6 (area under the curve, 0.603). Furthermore, using Process mediation analyses tool, we found statistically significant indirect effect of smoking and hypertension on future MI that is mediated through increased IL-6 binary complex or plasma IL-6. Conclusions: IL-6 and IL-6 binary complex concentration in plasma were significantly associated with future MI. Our data additionally imply that both the elevated plasma IL-6, and the IL-6 binary complex concentration could partly explain, and, thus, might hypothetically be functionally associated with the increased risk of MI in smokers and hypertensive participants.
引用
收藏
页码:1570 / 1579
页数:10
相关论文
共 50 条
  • [1] Risk of acute myocardial infarction among new users of chondroitin sulfate: A nested case-control study
    Mazzucchelli, Ramon
    Rodriguez-Martin, Sara
    Garcia-Vadillo, Alberto
    Gil, Miguel
    Rodriguez-Miguel, Antonio
    Barreira-Hernandez, Diana
    Garcia-Lledo, Alberto
    de Abajo, Francisco J.
    PLOS ONE, 2021, 16 (07):
  • [2] Apolipoprotein A2 Isoforms in Relation to the Risk of Myocardial Infarction: A Nested Case-Control Analysis in the JPHC Study
    Kihara, Tomomi
    Yamagishi, Kazumasa
    Honda, Kazufumi
    Ikeda, Ai
    Yatsuya, Hiroshi
    Saito, Isao
    Kokubo, Yoshihiro
    Yamaji, Taiki
    Shimazu, Taichi
    Sawada, Norie
    Iwasaki, Motoki
    Iso, Hiroyasu
    Tsugane, Shoichiro
    Group, Jphc Study
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (05) : 483 - 490
  • [3] The Association Between Dental Status and Risk of Acute Myocardial Infarction Among Poles: Case-control Study
    Gorski, Bartlomiej
    Nargiello, Ewa
    Grabowska, Ewa
    Opolski, Grzegorz
    Gorska, Renata
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 25 (05): : 861 - 870
  • [4] Association of shorter mean telomere length with risk of incident myocardial infarction: A prospective, nested case-control approach
    Zee, Robert Y. L.
    Michaud, Sherri E.
    Germer, Soren
    Ridker, Paul M.
    CLINICA CHIMICA ACTA, 2009, 403 (1-2) : 139 - 141
  • [5] The Association Between Arsenic Levels and Oxidative Stress in Myocardial Infarction: A Case-Control Study
    Sagha, Arian
    Shiri, Hamidreza
    Juybari, Kobra Bahrampour
    Mehrabani, Mehrnaz
    Nasri, Hamid Reza
    Nematollahi, Mohammad Hadi
    CARDIOVASCULAR TOXICOLOGY, 2023, 23 (1) : 61 - 73
  • [6] A nested case control study between melatonin secretion myocardial infarction of the association and incident
    McMullan, Ciaran J.
    Rimm, Eric B.
    Schernhammer, Eva S.
    Forman, John P.
    HEART, 2017, 103 (09) : 694 - 701
  • [7] Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis
    Brauchli, Y. B.
    Jick, S. S.
    Miret, M.
    Meier, C. R.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (05) : 1048 - 1056
  • [8] Risk of acute myocardial infarction among new users of bisphosphonates: a nested case-control study
    Mazzucchelli, R.
    Rodriguez-Martin, S.
    Garcia-Vadillo, A.
    Crespi-Villarias, N.
    Gil, M.
    Rodriguez-Miguel, A.
    Barreira, D.
    Garcia-Lledo, A.
    de Abajo, F. J.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (12) : 2403 - 2412
  • [9] Risk factors for acute myocardial infarction in patients with alcohol-related cirrhosis - a Danish nested case-control study
    Herting, Emma Celia
    Birn-Rydder, Rasmine
    Kazankov, Konstantin
    Jepsen, Peter
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2024, 59 (09) : 1069 - 1074
  • [10] Differential effects of antidepressant subgroups on risk of acute myocardial infarction: A nested case-control study
    Alqdwah-Fattouh, Rasha
    Rodriguez-Martin, Sara
    de Abajo, Francisco J.
    Gonzalez-Bermejo, Diana
    Gil, Miguel
    Garcia-Lledo, Alberto
    Bolumar, Francisco
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (10) : 2040 - 2050